Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survivalLucie E Jones, Michelle J Humphreys, Fiona Campbell, et al.
Cancer Research|August 3, 2005
p53 regulation and function in renal cell carcinomaHazel E Warburton, Mark Brady, Nikolina Vlatković, et al.
Cancer|January 7, 2010
p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?Aidan P Noon, Nikolina Vlatković, Radosław Polański, et al.
Nucleic Acids Research|April 25, 2003
Stimulation of human DNA polymerase epsilon by MDM2Hitomi Asahara, Ying Li, Jill Fuss, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|April 23, 2023
Whole genome DNA methylation and mutational profiles identify novel changes in proliferative verrucous leukoplakiaEyituoyo Okoturo, Daniel Green, Kim Clarke, et al.
Cancer Letters|July 29, 2014
Senescence induction in renal carcinoma cells by Nutlin-3: a potential therapeutic strategy based on MDM2 antagonismRadosław Polański, Aidan P Noon, Jeremy Blaydes, et al.
Cancer Research|May 3, 2008
MDM2 regulates dihydrofolate reductase activity through monoubiquitinationMaria Maguire, Paul C Nield, Timothy Devling, et al.
FEBS Letters|November 2, 2010
MDM2 promotes cell motility and invasiveness through a RING-finger independent mechanismRadosław Polański, Hazel E Warburton, Arpita Ray-Sinha, et al.
Cancers|October 13, 2021
Metabolic Plasticity and Combinatorial Radiosensitisation Strategies in Human Papillomavirus-Positive Squamous Cell Carcinoma of the Head and Neck Cell LinesMark D Wilkie, Emad A Anaam, Andrew S Lau, et al.
Cancer Letters|March 2, 2020
TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapiesMark D Wilkie, Emad A Anaam, Andrew S Lau, et al.
Pageof 3